Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HRS-7085 by Jiangsu Hengrui Medicine for Inflammatory Bowel Disease: Likelihood of Approval
HRS-7085 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Inflammatory Bowel Disease. According to...